The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
 
Cornelis Martinus van Tilburg
Consulting or Advisory Role - Novartis
 
Till Milde
No Relationships to Disclose
 
Jonas Ecker
No Relationships to Disclose
 
Angelika Seitz
No Relationships to Disclose
 
Jens-Peter Schenk
No Relationships to Disclose
 
Michael Fruehwald
No Relationships to Disclose
 
Arnulf Pekrun
No Relationships to Disclose
 
Claudia Rössig
Consulting or Advisory Role - Amgen; Celgene; Novartis; Pfizer; Roche/Genentech
 
Regina Wieland
No Relationships to Disclose
 
Christian Flotho
No Relationships to Disclose
 
Uwe Kordes
No Relationships to Disclose
 
Bernd Gruhn
No Relationships to Disclose
 
Thorsten Simon
No Relationships to Disclose
 
Christin Linderkamp
No Relationships to Disclose
 
Lenka Taylor
No Relationships to Disclose
 
Juergen Burhenne
Honoraria - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Irini Karapanagiotou-Schenkel
No Relationships to Disclose
 
Olaf Witt
Consulting or Advisory Role - AstraZeneca; Novartis